Johnson And Johnson Receivables Turnover Ratio (JNJ), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Johnson and Johnson  (NYSE: JNJ)
 

Johnson And Johnson Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Johnson And Johnson's ability to collect accounts receivable sequentially worsen to 5.45, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Average collection period, for Johnson And Johnson's accounts receivable remained unchanged at 67 days, in the Sep 27 2026 quarter.

If we take a look into Healthcare sector 346 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2426, from overall ranking in the second quarter 2026 at 2768.

What is Receivable Turnover Ratio?
What is Johnson And Johnson Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

JNJ Receivables Turnover Ratio (Sep 27 2026)
III. Quarter		 (Jun 28 2026)
II. Quarter		 (Mar 29 2026)
I. Quarter		 (Dec 28 2025)
IV. Quarter		 (Sep 28 2025)
III. Quarter
Y / Y Receivable Change 7.81 % 6.72 % 10.62 % 15.74 % 8.88 %
Y / Y Revenue Change 5.86 % 6.6 % 9.91 % 9.08 % 6.77 %
Receivable Turnover Ratio (TTM) 5.45 5.47 5.48 5.49 5.56
JNJ's Total Ranking # 2426 # 2768 # 2442 # 2471 # 2504
Accounts Receivable average collection period days 67 67 67 67 66
Seq. Receivable Change -0.31 % 7.48 % 3.16 % -2.46 % -1.32 %
Seq. Revenue Change 0.35 % 5.19 % -2.04 % 2.38 % 1.05 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 101
Healthcare Sector # 347
Overall Market # 2426

Receivable Turnover Ratio Statistics
High Average Low
7.06 6.07 5.45
(Sep. 30, 2005)   (Sep 27 2026)





JNJ Company Profile • Back to JNJ Efficiency Comparisons • Compare JNJ Receivables Turnover Ratio to its Competitors

Financial Statements
Johnson And Johnson's Accounts Receivable $ 18,987 Millions Visit JNJ's Balance sheet
Johnson And Johnson's Sales TTM $ 99,335 Millions Visit JNJ's Income Statement
Sources of JNJ's Revenues Visit JNJ's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
JNJ's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
JNJ's Growth Rates JNJ's Roa JNJ's Inventory Turnover Ratio JNJ's Dividend Comparisons
JNJ's Profitability Ratios JNJ's Roi JNJ's Asset Turnover Ratio JNJ's Dividend Growth
JNJ's Valuation Ratios JNJ's Roe JNJ's Financial Strength Ratios JNJ's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 27 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 27 2026 Receivable at quarter ending Sep 27 2026
Amneal Pharmaceuticals Inc   14.24 $ 3,196.184  Millions$ 224.488  Millions
Corcept Therapeutics Inc  13.44 $ 963.647  Millions$ 71.710  Millions
Precipio inc   13.38 $ 27.762  Millions$ 2.075  Millions
Chemed Corporation  12.65 $ 2,661.041  Millions$ 210.387  Millions
Caredx Inc   11.75 $ 497.396  Millions$ 42.330  Millions
Teladoc Health Inc   11.50 $ 2,468.143  Millions$ 214.604  Millions
Biodesix Inc   11.45 $ 105.212  Millions$ 9.192  Millions
Gossamer Bio Inc   11.37 $ 78.423  Millions$ 6.896  Millions
Icu Medical Inc  11.32 $ 2,183.556  Millions$ 192.845  Millions
Mannkind Corporation  10.97 $ 413.370  Millions$ 37.686  Millions
Lensar Inc   10.64 $ 60.079  Millions$ 5.645  Millions
Iqvia Holdings Inc   10.43 $ 17,311.000  Millions$ 1,659.500  Millions
Voyager Therapeutics Inc   9.84 $ 25.108  Millions$ 2.551  Millions
Myomo Inc   9.66 $ 47.775  Millions$ 4.947  Millions
Encompass Health Corporation  9.41 $ 6,338.100  Millions$ 673.625  Millions
Bausch Health Companies Inc   9.15 $ 11,113.000  Millions$ 1,215.000  Millions
Co diagnostics Inc   9.12 $ 0.859  Millions$ 0.094  Millions
Pacs Group Inc   8.88 $ 5,705.049  Millions$ 642.729  Millions
Lexicon Pharmaceuticals Inc   8.77 $ 38.537  Millions$ 4.396  Millions
Axogen inc   8.71 $ 266.926  Millions$ 30.654  Millions
Avita Medical Inc   8.65 $ 84.683  Millions$ 9.795  Millions
Ensign Group Inc  8.62 $ 5,674.305  Millions$ 658.477  Millions
Pediatrix Medical Group Inc   8.57 $ 1,959.124  Millions$ 228.471  Millions
Tenet Healthcare Corp  8.54 $ 22,154.000  Millions$ 2,593.250  Millions
Brightspring Health Services Inc   8.50 $ 9,479.144  Millions$ 1,114.763  Millions
Sotera Health Company  8.49 $ 1,230.250  Millions$ 144.974  Millions
Acadia Pharmaceuticals Inc   8.46 $ 1,202.301  Millions$ 142.117  Millions
Novavax inc   8.33 $ 411.649  Millions$ 49.414  Millions
Tactile Systems Technology Inc   8.23 $ 357.176  Millions$ 43.385  Millions
Penumbra Inc  8.22 $ 1,560.334  Millions$ 189.735  Millions

Date modified: 2026-10-22T05:13:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.